What is the history of remdesivir? From Ebola to the frontlines of COVID-19
•
4 min read
Originally developed in 2009 by Gilead Sciences, the antiviral drug remdesivir was initially intended to combat hepatitis C and respiratory syncytial virus (RSV) before being repurposed for its eventual, more famous applications. The history of remdesivir is a remarkable narrative of scientific repurposing, highlighting how a broad-spectrum antiviral candidate evolved from treating one family of viruses to becoming a key tool in global pandemic responses, including both Ebola and COVID-19.
